Research location
Hong Kong
Hong Kong, Hong Kong
Advertisement
Research activity in Hong Kong
Hong Kong, Hong KongCureCurrent currently publishes aggregate city-level research activity for this location: 37 trials and 40 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Hong Kong
36 linked trials · page 1 of 1Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon MutationsNCT07185997 · 2025-12-17 · 1 site observation
RECRUITING
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast CancerNCT07085767 · 2025-11-03 · 1 site observation
RECRUITING
Adjunctive Bright Light Therapy in Adolescents With Depression and EveningnessNCT06973759 · 2025-11-01 · 1 site observation
RECRUITING
Registry for Prostate Cancer Focal TherapyNCT07792590 · 2025-10-31 · 1 site observation
RECRUITING
Telemonitoring to Optimize Medication Titration for Heart Failure: a Feasibility StudyNCT07016815 · 2025-06-01 · 1 site observation
RECRUITING
Smartphone-based Self-Management Support Program to Enhance Quality of Life in Patients With COPDNCT06888557 · 2025-03-19 · 1 site observation
RECRUITING
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid TumorsNCT06784193 · 2024-12-16 · 1 site observation
RECRUITING
Can TElemedicine System Replace Doctor Consultations to Achieve Non-inferior Blood Pressure in Patients With Controlled HypertensionNCT06524180 · 2024-10-01 · 1 site observation
RECRUITING
Effect of JAK Inhibitor on Erosion Healing in RANCT05955066 · 2023-12-01 · 1 site observation
RECRUITING
Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADENCT06000865 · 2023-09-09 · 1 site observation
RECRUITING
The Application of Somatosensory Interactive Pelvic Floor Muscle Training for Stress Urinary Incontinence in Men Underwent Radical ProstatectomyNCT06740071 · 2023-05-01 · 1 site observation
RECRUITING
Screening for Lung Cancer in Subjects With Family History of Lung CancerNCT05762731 · 2023-02-01 · 1 site observation
RECRUITING
A Longitudinal Follow-Up Study on Predicting Major Depressive Disorder From Rest-Activity Rhythm ProfilesNCT07388849 · 2026-02-01 · 1 site observation
NOT_YET_RECRUITING
Effects of the EatWelLog App on Diet Management for Older Adults With Sarcopenic ObesityNCT06360432 · 2024-04-08 · 1 site observation
COMPLETED
Increasing Physical Activity Through Personalised Motivational Messaging to Improve Cognitive Function in Lung Cancer SurvivorsNCT06003335 · 2024-02-01 · 1 site observation
COMPLETED
A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)NCT06018337 · 2024-01-18 · 2 site observations
ACTIVE_NOT_RECRUITING
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerNCT06016738 · 2023-11-16 · 1 site observation
ACTIVE_NOT_RECRUITING
Co-design and Pilot Study in VR-based Physical Activity and Cognitive TrainingNCT06982170 · 2023-10-01 · 1 site observation
COMPLETED
Dietary Programme and Exercise Training in Combination or Separately on Managing Sarcopenic Obesity in Older AdultsNCT05734755 · 2023-03-15 · 1 site observation
ACTIVE_NOT_RECRUITING
The Effectiveness of a One-stop Electronic Clinic for Psychological Service (eClinic) in Hong KongNCT07597967 · 2022-12-28 · 1 site observation
COMPLETED
Virtual Reality Exercise Program for People with Type 2 DiabetesNCT05794009 · 2022-06-01 · 1 site observation
COMPLETED
Chemsex Engagement and HIV Biomedical Prevention in MSMNCT05031832 · 2021-06-01 · 1 site observation
COMPLETED
Circulating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung AdenocarcinomaNCT03090815 · 2016-02-01 · 1 site observation
UNKNOWN
Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by MetforminNCT01766778 · 2013-05-13 · 1 site observation
COMPLETED
Impact of Sleep Education Program on Glycemic Control in Hong Kong Chinese Type 2 Diabetic PatientsNCT01881724 · 2013-05-01 · 1 site observation
UNKNOWN
Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential HypertensionNCT01785472 · 2013-04-01 · 1 site observation
COMPLETED
Efficacy and Safety of QMF149 vs. Salmeterol Xinafoate/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT01636076 · 2012-11-01 · 1 site observation
COMPLETED
Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential HypertensionNCT01615198 · 2012-08-01 · 1 site observation
COMPLETED
Efficacy and Tolerability of Symbicort as an add-on Treatment to Spiriva Compare With Spiriva Alone in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD)NCT01397890 · 2011-07-01 · 1 site observation
COMPLETED
The Roles of Neutrophil Elastase in Lung CancerNCT01360931 · 2011-01-01 · 1 site observation
UNKNOWN
Efficacy and Safety of Alogliptin in Participants With Type 2 DiabetesNCT01289119 · 2010-12-01 · 1 site observation
COMPLETED
Efficacy and Safety Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive DisorderNCT01255787 · 2010-11-01 · 1 site observation
COMPLETED
To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC)NCT01185314 · 2010-09-01 · 1 site observation
COMPLETED
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart FailureNCT01035255 · 2009-12-01 · 1 site observation
TERMINATED
Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease PatientsNCT00745914 · 2008-09-01 · 1 site observation
COMPLETED
A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone MetastasesNCT00554229 · 2007-11-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.